BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1098 related articles for article (PubMed ID: 33524866)

  • 1. COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation.
    Salabei JK; Fishman TJ; Asnake ZT; Ali A; Iyer UG
    Heart Lung; 2021; 50(2):357-360. PubMed ID: 33524866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19-induced coagulopathy: Experience, achievements, prospects.
    Dubey L; Dorosh O; Dubey N; Doan S; Kozishkurt O; Duzenko O; Kozlova O; Ievtukh V; Ladny JR; Pruc M; Szarpak L; Pukach J
    Cardiol J; 2023; 30(3):453-461. PubMed ID: 36588310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coagulopathy, endotheliopathy, and vasculitis of COVID-19.
    Iba T; Connors JM; Levy JH
    Inflamm Res; 2020 Dec; 69(12):1181-1189. PubMed ID: 32918567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
    Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
    Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation abnormalities & thromboprophylaxis in COVID-19.
    Jandial A; Gupta A; Malviya A; Agastam S; Kumar D
    Indian J Med Res; 2021 May&Jun; 153(5&6):606-618. PubMed ID: 34643567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covid-19-induced coagulopathy and observed benefits with anticoagulation.
    Karimzadeh S; Dong V; Hassan OG; Raut A; Fouda A; Parrill A; Eaton K; Huy NT
    Transfus Apher Sci; 2020 Dec; 59(6):102906. PubMed ID: 32778522
    [No Abstract]   [Full Text] [Related]  

  • 7. COVID-19-associated coagulopathy: a concise review on pathogenesis and clinical implications.
    Memar Montazerin S; Najafi H; Shojaei F; Chi G; Goudarzi S; Sharfaei S; Kahe F; Hassanzadeh S
    Infez Med; 2021 Mar; 29(1):1-9. PubMed ID: 33664168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
    Eljilany I; Elzouki AN
    Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coagulopathy in COVID-19.
    Iba T; Levy JH; Levi M; Thachil J
    J Thromb Haemost; 2020 Sep; 18(9):2103-2109. PubMed ID: 32558075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of COVID-19 Disease on Platelets and Coagulation.
    Wool GD; Miller JL
    Pathobiology; 2021; 88(1):15-27. PubMed ID: 33049751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coagulopathy during COVID-19 infection: a brief review.
    Cunningham RM; Johnson Moore KL; Moore JS
    Clin Exp Med; 2023 Jul; 23(3):655-666. PubMed ID: 36121504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulopathy in COVID-19 and anticoagulation clinical trials.
    Zhang H; Lao Q; Zhang J; Zhu J
    Best Pract Res Clin Haematol; 2022 Sep; 35(3):101377. PubMed ID: 36494146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Overview on Hypercoagulability in COVID-19.
    Singhania N; Bansal S; Nimmatoori DP; Ejaz AA; McCullough PA; Singhania G
    Am J Cardiovasc Drugs; 2020 Oct; 20(5):393-403. PubMed ID: 32748336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to the Patient with COVID-19-Associated Thrombosis: A Case-Based Review.
    Chen EC; Zon RL; Battinelli EM; Connors JM
    Oncologist; 2020 Oct; 25(10):e1500-e1508. PubMed ID: 32881209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation and anticoagulation in COVID-19.
    Hadid T; Kafri Z; Al-Katib A
    Blood Rev; 2021 May; 47():100761. PubMed ID: 33067035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.
    Hayıroğlu Mİ; Çınar T; Tekkeşin Aİ
    Rev Assoc Med Bras (1992); 2020 Jun; 66(6):842-848. PubMed ID: 32696883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 coagulopathy: is it disseminated intravascular coagulation?
    Levi M; Iba T
    Intern Emerg Med; 2021 Mar; 16(2):309-312. PubMed ID: 33368021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19: coagulation disorders and anticoagulant treatment in patients hospitalised in ICU.
    Pluta J; Cieniewicz A; Trzebicki J
    Anaesthesiol Intensive Ther; 2021; 53(2):153-161. PubMed ID: 34006056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [COVID-19: Coagulopathy and thrombosis].
    Tazi Mezalek Z
    Rev Med Interne; 2021 Feb; 42(2):93-100. PubMed ID: 33509669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peculiarities of blood coagulation disorders in patients with COVID-19].
    Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI
    Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.